Anthem Biosciences Ltd. - Research Center

---

Results

Statement

• Balance sheet

More

Mar ' 25	Mar ' 24	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

111.82

111.82

8.78

8.48

Share application money

-

-

-

-

Preference share capital

-

-

-

-

Reserves & surplus

2,361.40

1,821.26

1,345.04

691.35

Loan funds

Secured loans

108.95

166.59

37.13

101.65

Unsecured loans

-

-

-

-

Total

2,582.17

2,099.66

1,390.95

801.48

Uses of funds

Fixed assets

Gross block

1,187.58

971.42

690.64

670.31

Less : revaluation reserve

-

-

-

-

Less : accumulated depreciation

563.53

493.71

361.63

308.90

Net block

624.06

477.71

329.01

361.41

Capital work-in-progress

57.94

155.91

152.68

18.59

Investments

533.22

471.77

272.98

209.27

Net current assets

Current assets, loans & advances

1,620.35

1,218.83

864.51

444.47

Less : current liabilities & provisions

253.40

224.56

228.22

232.25

Total net current assets

1,366.95

994.27

636.29

212.22

Miscellaneous expenses not written

-

-

-

-

Total

2,582.17

2,099.66

1,390.95

801.48

Notes:

Book value of unquoted investments

117.08

12.70

-

-

Market value of quoted investments

-

-

-

-

Contingent liabilities

136.27

444.60

255.78

100.27

Number of equity sharesoutstanding (Lacs)

5590.77

5590.77

87.76

84.85